Home
Clinical Resources Search
PQI: Niraparib (Zejula®): Dose Modifications Based on Weight and Platelet Counts

Niraparib (Zejula®): Dose Modifications Based on Weight and Platelet Counts

Download PQI pdf

Last Updated: October 4, 2023

By: Michelle Phillips, PharmD

About this PQI

The purpose of this PQI is to highlight key criteria for appropriate monitoring, dosing, and administration to improve the dispensing and management of patients taking niraparib.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Niraparib (Zejula®): Dose Modifications Based on Weight and Platelet Counts

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Tafasitamab-cxix (Monjuvi) for Relapsed/Refractory Follicular Lymphoma

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Reflex Biomarker Testing in Metastatic Colorectal Cancer: Implementing BRAF and MSI Assessment

PQI: Amivantamab and Hyaluronidase plus Lazertinib Patient Management

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E6: Finding the Heart of Oncology

S11 E5: Keep Marching On: Changing the Story of Pancreatic Cancer

S11 E4: From Data to Decisions: Decoding Prostate Cancer Updates

S11 E3: Beyond Borders: Bringing Cancer Treatment Within Reach

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Avutometinib and Defactinib

Treatment Support Kit: Mirdametinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Niraparib

Abiraterone and Niraparib

PQI: PARP Inhibitor Eligibility in Ovarian Cancer

PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices

Niraparib

PQI: PARP Inhibitor Eligibility in Ovarian Cancer

PQI in Action: Multidisciplinary Management of Advanced Ovarian Cancer Patients within Medically Integrated Pharmacy Practices

S11 E6: Finding the Heart of Oncology

Daraxonrasib

Cisplatin and Radiation

Palbociclib and Trastuzumab